Sibutramine in clinical practice

International Journal of Obesity

Volumn 25, Issue , 2001, Pages S12-S15

  Finer, N ^a  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Clinical issues; Initial weight loss; Predicting response; Sibutramine

Indexed keywords

SIBUTRAMINE;

CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DIET THERAPY; DRUG EFFICACY; DRUG USE; EXERCISE; HEALTH PROGRAM; HUMAN; OBESITY; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

APPETITE DEPRESSANTS; CLINICAL TRIALS; CYCLOBUTANES; HUMANS; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES;

EID: 0035702665     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801932     Document Type: Article

References (6)

1. Apfelbaum M, Vague P, Ziegler O, Hanotin C; Thomas F; Leute- negger E. Long-term maintenance of weight loss after a very-low- calorie diet: a randomized blinded trial of the efficacy and toler- ability of sibutramine. Am/Med 1999; 106: 179-184.
2. Fames WPT, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-2125.
3. Smith IG, Goulder MA on behalf of the Members of the Sibutramine Clinical Study Team. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.Fani Pract 2001; 50: 505-512.
4. Rissanen A, Pekkarinen T, Heinanen T, Saltevo J, Taskinen MR. Weight loss profile with sibutramine in obese patients with type 2 diabetes: a double-blind, placebo-controlled study. Obes Res 1999; 7(Suppl 1): 93S.
5. McNulty S, Williams G for the International Study Group, Diabetes and Endocrinology Research Group. Sibutramine is effective for weight loss in obese, metformin-treated Type 2 diabetics. Int J Obes Rei at Metab Disord 2000; 24(Suppl 1): S320.
6. Scholze J. Weight reduction by sibutramine in a primary care setting. Int J Obes Relat Metab Disord 2001; 25(Suppl 2): S106. Presentation at NAASO 2000.